News

AZ Central5d
There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate ...
NanoViricides has chosen MPox as the first indication to advance NV-387 into Phase II clinical trials out of the four indications for which the Company has substantial efficacy data in animal ...
The Courier-Journal5d
There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug ... - Courier-Journal
NanoViricides has chosen MPox as the first indication to advance NV-387 into Phase II clinical trials out of the four indications for which the Company has substantial efficacy data in animal ...
Health.com29d
Do You Have Monkeypox (Mpox)? Everything You Need To Know - Health
If necessary, they may also perform other diagnostic testing to rule out other conditions like HIV, varicella-zoster viruses, such as chicken pox or shingles, herpes, or syphilis.